Whether patients with sporadic or familial IPF present with mutations in Ing4, as it happens with telomerase [36-39], and whether these mutations affect ING4 expression and are associated with patients' survival and treatment response, remains to be proven. The gene discussed is ING4; the disease is idiopathic pulmonary fibrosis.